Shared on 01 May 25
Fair value Increased 5.93%Expanding Hospital Networks And Digital Health Will Fuel Growth
Shared on 24 Apr 25
Tissue Health Plus And OsStic Will Expand Market Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Tissue Health Plus And OsStic Will Expand Market Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Tissue Health Plus And OsStic Will Expand Market Reach
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 3.67%Tissue Health Plus And OsStic Will Expand Market Reach
AnalystConsensusTarget has decreased revenue growth from 15.5% to 13.2%, increased future PE multiple from 29.4x to 32.7x and increased shares outstanding growth rate from 0.0% to 0.0%.